Skip to main content

Day: August 24, 2022

HSBC Bank Plc – Form 8.5 (EPT/RI) – Bank of Cyprus Holdings plc

Ap34 FORM 38.5(a) (EPT/RI) IRISH TAKEOVER PANEL DEALING DISCLOSURE UNDER RULE 38.5(a) OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVER RULES, 2022 BY A CONNECTED EXEMPT PRINCIPAL TRADER WITH RECOGNISED INTERMEDIARY STATUS AND DEALING IN A CLIENT-SERVING CAPACITY 1.            KEY INFORMATION(a)   Name of exempt principal trader: HSBC Bank Plc(b)   Name of offeror/offeree in relation to whose relevant securities this form relates: Use a separate form for each offeror/offeree Bank of Cyprus Holdings plc(c)   Name of the party to the offer with which exempt principal trader is connected: (Note 1) Offeree – Bank of Cyprus Holdings plc(d)   Date dealing undertaken: 23-August-2022(e)   In addition to the company in 1(b) above, is the exempt principal trader also making disclosures in respect of any other...

Continue reading

Aurora Mobile Participated in Drafting the Group Standard of Mobile App SDK Security Technical Requirements and Test Methods Officially Released Recently

SHENZHEN, China, Aug. 24, 2022 (GLOBE NEWSWIRE) — Aurora Mobile Limited (NASDAQ: JG) (“Aurora Mobile” or the “Company”), a leading provider of customer engagement and marketing technology services in China, today announced that the Group Standard of Mobile App SDK Security Technical Requirements and Test Methods (the “Standard”) that the Company Participated in drafting has been officially released and will be implemented on November 5, 2022. The Standard was initiated by the China Academy of Information and Communications Technology (“CAICT”) and was officially established as a project of the Internet Society of China on September 10, 2021. Under instruction and guidance from CAICT, Aurora Mobile fully leveraged its extensive experience and expertise in data compliance and personal information protection and participated in the...

Continue reading

Hywin Holdings to Announce Second Half and Full Year of Fiscal 2022 Financial Results on August 31, 2022

SHANGHAI, China, Aug. 24, 2022 (GLOBE NEWSWIRE) — Hywin Holdings Ltd. (“Hywin,” or the “Company”) (NASDAQ: HYW), a leading independent wealth management service provider in China, today announced that it plans to report its unaudited financial results for the second half and full year of fiscal 2022 ended June 30, 2022, before the market opens on Wednesday, August 31, 2022. Hywin’s management will hold a conference call on Wednesday, August 31, 2022 at 8:00 A.M. Eastern Time (8:00 P.M. Beijing Time on the same day) to discuss the financial results. Details for the conference call are as follows:Event Title: Hywin Holdings Ltd. Second Half and Full Year of Fiscal 2022 Earnings Conference CallRegistration Link: https://register.vevent.com/register/BI9738d0cc38844fceb7ede8b495ad19b9All participants must use the link provided...

Continue reading

Alvotech to Participate in Two Upcoming Investor Conferences in September 2022

Alvotech (NASDAQ: ALVO), a global biotech company specialized in the development and manufacture of biosimilar medicines for patients worldwide, announced today that members of the leadership team will participate in two upcoming investor conferences in September 2022. Representatives of Alvotech will hold two fireside chats:At Citi’s 17th Annual Biopharma Conference: Thursday, September 8, 2:40 pm ET At Morgan Stanley’s 20th Annual Global Healthcare Conference: Monday, September 12,  2:15 pm ETFollowing the conferences, a replay of the webcast will be available in the Investors Section of Alvotech’s website under News and Events – Events and Presentations, for 90 days.   About Alvotech Alvotech is a biotech company, founded by Robert Wessman, focused solely on the development and manufacture of biosimilar medicines for patients worldwide....

Continue reading

Alvotech to Participate in Two Upcoming Investor Conferences in September 2022

REYKJAVIK, Iceland and NEW YORK, Aug. 24, 2022 (GLOBE NEWSWIRE) — Alvotech (NASDAQ: ALVO), a global biotech company specialized in the development and manufacture of biosimilar medicines for patients worldwide, announced today that members of the leadership team will participate in two upcoming investor conferences in September 2022. Representatives of Alvotech will hold two fireside chats:At Citi’s 17th Annual Biopharma Conference: Thursday, September 8, 2:40 pm ET At Morgan Stanley’s 20th Annual Global Healthcare Conference: Monday, September 12, 2:15 pm ETFollowing the conferences, a replay of the webcast will be available in the Investors Section of Alvotech’s website under News and Events – Events and Presentations, for 90 days. About Alvotech Alvotech is a biotech company, founded by Robert Wessman, focused solely on...

Continue reading

Arcoma receives order of 8 systems to Thailand (MAR)

2022-08-24 PRESSRELEASE Arcoma receives order of 8 systems to Thailand Arcoma AB has received an order of 8 X-ray systems to Thailand. The total order value is approximately 5-6 MSEK and the systems will be installed during Q3 2022 – Q1 2023. This order include the first Arcoma Precision i5 to Thailand. The order is placed by Thai GL, who is Arcoma’s distributor and partner in Thailand. The Arcoma Precision i5 is Arcoma´s latest X-ray system developed with focus on efficient workflow, safety and ease of use. The ergonomic design and the auto positioning technology maximizes the patient throughput and improves patient and user experience. “It has been an exciting journey to work with our hospitals to plan and install the state of art Digital X-ray systems from Arcoma that can benefit both healthcare workers and the patients”,...

Continue reading

UCLOUDLINK GROUP INC. Announces Unaudited Second Quarter 2022 Financial Results

HONG KONG, Aug. 24, 2022 (GLOBE NEWSWIRE) — UCLOUDLINK GROUP INC. (“UCLOUDLINK” or the “Company”) (NASDAQ: UCL), the world’s first and leading mobile data traffic sharing marketplace, today announced its unaudited financial results for the three months ended June 30, 2022. Second Quarter 2022 Financial HighlightsTotal revenues were US$18.0 million, representing a decrease of 6.3% from US$19.2 million in the second quarter of 2021. Gross profit was US$8.0 million, representing an increase of 47.2% from US$5.4 million in the second quarter of 2021. Loss from operations was US$5.8 million, compared to a loss from operations of US$8.2 million in the second quarter of 2021. Net loss was US$6.3 million, compared to a net loss of US$8.2 million in the second quarter of 2021. Adjusted net loss (non-GAAP) was US$1.5 million, compared...

Continue reading

Issue of additional 3MEUR Green Bonds issue of UAB Atsinaujinančios Energetikos Investicijos

The Company on 23 August 2022, has successfully distributed under private placement additional 3MEUR Green Bonds issue at 6,5% yield under Company’s 100MEUR Note Programme. Additional issued bonds will be tapped to already issued bonds under ISIN LT0000405938. The bonds were subscribed by individuals and legal entities. The additional 3MEUR Green Bonds issue (issue date 26 August 2022) is expected to be listed on the Baltic Bond main list of Nasdaq Vilnius, thereby supplementing the previously listed bonds under ISIN LT0000405938, during the period of 30 days after the date hereof. Additional information:Issuer’s full name UAB „Atsinaujinančios Energetikos Investicijos“Issuer’s short name AEIB050025ASecurities ISIN code LT0000405938Nominal value of one bond 100 000 EURNumber of additional bonds 30Total number...

Continue reading

Strong sales growth and profitability in H1; volatile environment leads to lower full-year EBIT margin estimate

Report on the first half year of 2022for ROCKWOOL A/SRelease no. 10 – 2022to Nasdaq Copenhagen 24 August 2022 Strong sales growth and profitability in H1; volatile environment leads to lower full-year EBIT margin estimate HighlightsSales in H1 2022 reached 1942 MEUR, an increase of 31 percent in local currencies compared to H1 last year. Sales in Q2 2022 amounted to 1018 MEUR, an increase of 26 percent in local currencies compared to Q2 2021. Volume remained stable at a high level during the quarter. EBITDA in H1 2022 reached 342 MEUR, up 14 percent, with a 17.6 percent EBITDA margin. EBITDA in Q2 2022 reached 187 MEUR, an increase of 17 percent. Due to the soaring energy and material costs EBITDA margin at 18.4 percent was down 2.2 percentage points from last year.EBIT in H1 2022 increased 16 percent to 233 MEUR, with a 12.0 percent...

Continue reading

Interim Report Q2 2022

Company announcement no. 21/2022 Revenue growth of 4% in Q2 2022 ”Our efforts to improve efficiency starts materializing. In Q2 2022 efficiency was 64% and continues to be one of our key performance indicators to improve.”, says CEO & President Søren Krogh Knudsen. Q2 highlightsRevenue growth of 4% amounting to DKK 390m EBITDA decline of 30% amounting to DKK 16m Improvement of efficiency to 64% up from 59% in Q4 2021 Hiring of new CFO Brian Iversen Hiring of key leadership positions in Market Units and Business Lines Launch of new leadership principles Pricing and cost initiativesH1 highlightsRevenue growth of 6% amounting to DKK 783m EBITDA decline of 25% amounting to DKK 46m Divestment of Columbus Russia with a negative effect of DKK 25m Focus on improving efficiency Stable number of employees Strengthening our one Columbus...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.